Rationale and study design of the INcrease Of Vagal TonE in Heart Failure study: INOVATE-HF
- 1 June 2012
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 163 (6), 954-962.e1
- https://doi.org/10.1016/j.ahj.2012.03.021
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceThe Lancet, 2011
- Recruitment and blocking properties of the CardioFit stimulation leadJournal of Neural Engineering, 2011
- Beta-Adrenergic Blockers for Chronic Heart FailureCardiology in Review, 2009
- Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing ModelCirculation: Heart Failure, 2009
- Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trialsEuropean Heart Journal, 2009
- Randomized Controlled Trial of an Implantable Continuous Hemodynamic Monitor in Patients With Advanced Heart Failure: The COMPASS-HF StudyJournal of the American College of Cardiology, 2008
- A Comparison of the Effects of Carvedilol and Metoprolol on Well-Being, Morbidity, and Mortality (the “Patient Journey”) in Patients With Heart Failure: A Report From the Carvedilol Or Metoprolol European Trial (COMET)Journal of the American College of Cardiology, 2006
- Efferent Vagal Nerve Stimulation Protects Heart Against Ischemia-Induced Arrhythmias by Preserving Connexin43 ProteinCirculation, 2005
- Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarctionThe Lancet, 1998
- Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death.Circulation, 1982